跳至主要内容
临床试验/EUCTR2007-000518-34-DK
EUCTR2007-000518-34-DK进行中(未招募)不适用

Effect of beta blockade on left ventricular remodeling and function in aortic regurgitation

Rikshospitalet0 个研究点目标入组 70 人开始时间: 2011年9月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The criteria for enrollment in the study are asymptomatic aortic regurgitation of moderate to severe degree..
  • Inclusion criteria
  • (i)Age of 18-70 years
  • (ii)Stable clinical situation
  • (iii)Have LVEF >55%,
  • (iv)Have an end diastolic diameter (on echo) of 50-60 mm
  • (v)Have given written informed consent
  • (vi)No planned surgery
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • (i)Evidence of unstable disease
  • (ii)Mixed aortic stenosis and regurgitation (valve gradients > 20 mm Hg).
  • (iii)evidence of additional valvular or congenital heart disease on echocardiographic or Doppler study
  • (iv)EF< 55%
  • (v)LVESD>55 mm
  • (vi)Heart rate < 50 bpm
  • (vii)Other illnesses or treatments which reduces the safety and/or efficacy of the treatment
  • (viii)Participating in other studies

研究者

发起方
Rikshospitalet

相似试验